Self-inhibition of HER2 at fever temperatures may prevent dimerization with HER3
The paper uses molecular dynamics simulations to show that HER2 adopts an inactive conformation at 40°C, preventing dimerization with HER3, suggesting fever temperatures could modulate HER2 activity in cancer treatment.
bioRxiv · Jan 22, 2023 · PreprintCancer Biology